Table 1. Characteristics of eligible... | American Society of Hematology

Table 1.

Characteristics of eligible patients

	All patients, n = 34
Characteristic	No. of patients	Percent of patients
Sex, female	11	32
Durie-Salmon stage
I	4	12
II	14	41
III	16	47
ISS stage
I	14	41
II	16	47
III	4	12
Immunoglobulin heavy chain type
IgG	16	47
IgA	11	32
Light chain only, Bence Jones protein	7	21
Anemia, hemoglobin level less than 110 g/L	14	41
Lytic bone lesions	19	59
Beta 2-microglobulin level greater than 2.7 mg/L	18	53
Lactate dehydrogenase level 250 U/L or greater	5	15
Bone marrow plasma-cell percentage 40% or greater	10	31

	All patients, n = 34
Characteristic	No. of patients	Percent of patients
Sex, female	11	32
Durie-Salmon stage
I	4	12
II	14	41
III	16	47
ISS stage
I	14	41
II	16	47
III	4	12
Immunoglobulin heavy chain type
IgG	16	47
IgA	11	32
Light chain only, Bence Jones protein	7	21
Anemia, hemoglobin level less than 110 g/L	14	41
Lytic bone lesions	19	59
Beta 2-microglobulin level greater than 2.7 mg/L	18	53
Lactate dehydrogenase level 250 U/L or greater	5	15
Bone marrow plasma-cell percentage 40% or greater	10	31

IgG indicates immunoglobulin G; and ISS, International Staging System.